Intercalating Fluorescent Dyes for Nucleic Acid Labeling

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional intercalating fluorescent dyes used for nucleic acid analysis suffer from instability in chemical environments, leading to rapid deterioration of stability and fluorescence efficiency, and are cytotoxic, limiting their application in biofield analysis.

Innovation Solution

A novel intercalating fluorescent compound with a specific chemical structure (represented by Chemical Formula 1) that exhibits excellent stability and high fluorescence efficiency, capable of maintaining fluorescence properties over time, and is biosafe for use in analyzing nucleic acids like DNA and RNA, with a narrower wavelength range and high absorption and fluorescence intensity at pH 7, suitable for in vivo imaging.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Illumination intensity

If conventional intercalating fluorescent dyes are used for nucleic acid analysis, then fluorescence efficiency is achieved, but stability deteriorates rapidly in chemical environments

Engineering Contradiction:
Improvefluorescence efficiencyVSAvoidstability
Core Design Contradiction:
Illumination intensityVSStability of the object's composition

Solution Approach 1:

The patent modifies the chemical structure parameters of fluorescent dyes by introducing specific substituents (electron-withdrawing groups like -SO3H, -COOH, -F, -Cl at positions 5, 6, 7 of the xanthene ring) to enhance both stability and fluorescence efficiency simultaneously, resolving the contradiction between rapid deterioration and performance maintenance

Inventive Principle:
Principle #35Parameter changes

2Productivity

If conventional fluorescent dyes are used for labeling, then binding efficiency with nucleic acids is achieved, but cytotoxicity occurs

Engineering Contradiction:
Improvebinding efficiencyVSAvoid cytotoxicity
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The patent introduces specific functional groups at specific positions (5, 6, 7 of xanthene ring) to create localized chemical properties that reduce cytotoxicity while preserving binding efficiency, allowing the dye to interact selectively with nucleic acids without harmful effects on cells

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent converts potentially harmful interactions into beneficial ones by designing dyes that can bind to nucleic acids with high efficiency while the modified structure prevents cytotoxic effects, turning a harmful dye into a biosafe probe for cellular applications

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

3Measurement precision

If fluorescent dyes are used for in vivo imaging, then detection capability is achieved, but storage stability is poor

Engineering Contradiction:
Improvedetection capabilityVSAvoidstorage stability
Core Design Contradiction:
Measurement precisionVSDuration of action of stationary object

Solution Approach 1:

The patent creates composite fluorescent dye molecules combining xanthene core structure with specific substituents (-SO3H, -COOH, -F, -Cl) that provide both detection capability through fluorescence and storage stability through enhanced chemical resistance, enabling long-term storage and in vivo imaging applications

Inventive Principle:
Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The compound maintains fluorescence stability and efficiency, is non-cytotoxic, and effectively detects biomaterials, including nucleic acids, with enhanced storage stability and biosafety, making it suitable for various biofield analyses without limiting to specific cells or tissues.

Implementation Method 1

emit fluorescence by inserting a fluorescent compound between nucleic acid molecules having a double helix structure such as DNA and RNA

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Implementation Method 2

have excitation and fluorescence wavelengths suitable for fluorescence equipment

Methodology Applied
Scientific EffectAbsorption of light: Absorption (EM radiation)

Data Source

PatentUS11667961B2Intercalating fluorescent dyes for labelling nucleic acids and preparation method thereof
Publication Date: 2023.06.06 BIOACTS
  • US11667961B2 patent drawing
  • US11667961B2 patent drawing
  • US11667961B2 patent drawing

AI summary

The novel intercalating fluorescent compounds of exemplary embodiments of the present invention for analyzing nucleic acids, etc. have excellent intercalating efficiency with nucleic acids such as DNA and RNA of biomaterials, and may not only continuously maintain fluorescence properties and efficiency, but also have excellent effects even in terms of storage stability such as temperature and moisture, etc. and biosafety. In addition, the fluorescent compounds have various advantages capable of being dissolved in distilled water, which is a solvent harmless to the human body, and being applied to a wide range of analysis without being limited to the analysis of specific cells and living tissues.